Amoxicillin
Product Images NDC 10544-434

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 10544-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 875mg 20ct (Label Amoxicillin Caps 875mg Bpi(10544 434 20) West Ward(0143 9951 01) Rev1)

Label 875mg 20ct (Label Amoxicillin Caps 875mg Bpi(10544 434 20) West Ward(0143 9951 01) Rev1)
This is a description of a medicine which is Amoxicillin, packaged as tablets in a bottle that contains twenty (20) Tablets. Each tablet is 875mg, and it is strictly for use by prescription only. Information on dosage is provided in the included package insert. The medication must be stored at room temperature between 20°-25°C (66°-77°F), with packaging by the manufacturer identified as West-ward Pharmaceutical Corp and packaged By Blenneim Pharmacal with lot and expiry date noted.*
FDA Label Image

Table 1 (Amoxicillin 875 Hikma 1)

Table 1 (Amoxicillin 875 Hikma 1)
This is a dosing recommendation table that provides guidance for the usage of amoxicillin in treating different types of bacterial infections in adult and pediatric patients over three months of age. The table shows the recommended dosages for each type of infection and specifies that children weighing less than 40 kg should follow the children's dosage recommendations while those weighing 40 kg or more should use the adult recommendations. The dosage for infections caused by bacteria that are intermediate in their susceptibility to amoxicillin should follow the recommendations for severe infections. There is also a note concerning the usage of amoxicillin in the treatment of uncomplicated ano-genital and urethral infections in children under two years.*
FDA Label Image

Chemical Structure (Amoxicillin 875 Hikma 2)

FDA Label Image

Table 3 (Amoxicillin 875 Hikma 3)

Table 3 (Amoxicillin 875 Hikma 3)
This is a table showing the pharmacokinetic parameters of two forms of the antibiotic Amoxicillin: 400mg/5ml suspension and 400mg chewable tablets. These parameters were measured in a group of 24 healthy adults, and include the area under the curve (AUC) and peak concentrations of Amoxicillin in the blood. The medicine was administered at the start of a light meal and peak concentrations were reached approximately 1 hour after the dose.*
FDA Label Image

Bacteria (Amoxicillin 875 Hikma 4)

Bacteria (Amoxicillin 875 Hikma 4)
This is a list of different types of bacteria categorized as Gram-positive and Gram-negative. The Gram-positive bacteria include Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. The Gram-negative bacteria include Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*
FDA Label Image

Table 4 (Amoxicillin 875 Hikma 5)

Table 4 (Amoxicillin 875 Hikma 5)
This is a table outlining the interpretation criteria for the susceptibility test of amoxicillin against various bacteria. The table includes specific minimum inhibitory concentration, disk diffusion zone diameter, and susceptible, intermediate, or resistant categories for Enterococcus spp., Staphylococcus spp., different groups of Streptococci, Enterobacteriaceae, Haemophilus influenzae, and Neisseria gonorrhoeae. Also included is a note specifying how to test Streptococcus pneumoniae using oxacillin disk, and the interpretation of amoxicillin resistance for isolates that are resistant to enitiiin b MIC.*
FDA Label Image

Table 5 (Amoxicillin 875 Hikma 6)

Table 5 (Amoxicillin 875 Hikma 6)
Table 5 shows acceptable quality control ranges for amoxicillin based on the minimum inhibitory concentration (MIC) and disk diffusion zone range for various bacterial strains obtained from the American Type Culture Collection (ATCC). The bacterial strains evaluated in this table include Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae. The acceptable range for the MIC for these strains ranges from 0.5 to 32 μg/mL, while the disk diffusion zone range ranges from 13 to 35 mm.*
FDA Label Image

Table 6 (Amoxicillin 875 Hikma 7)

Table 6 (Amoxicillin 875 Hikma 7)
This is a table with data on H. pylori eradication rates for a triple therapy that includes amoxicillin. The table includes the results of two different studies and provides information on both an evaluable analysis and an intent-to-treat analysis, along with their corresponding confidence intervals. The analysis was based on patients with confirmed H. pylori infection and a duodenal ulcer, and patients who dropped out due to adverse drug events were included as failures.*
FDA Label Image

Table 7 (Amoxicillin 875 Hikma 8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.